Videos
Share this video:
Post on twitter:
New Models of Innovation in Life Sciences – MaRS Market Insights
Increasing costs and decreased productivity have hampered growth and investment in the global life sciences and health-care sector. The open-innovation approach embraced by many industries could transform the way biotech and health-care companies innovate—bringing products and services to market quickly and efficiently.
What does this mean for business and consumers in Ontario?
Presenting diverse perspectives, this breakfast panel examines the open-innovation approach and identifies opportunities and challenges for health-care stakeholders as they position themselves in the value chain. Learn how to use this approach and leverage it with success.
Moderator:
John McCulloch, Senior Advisor, Life Sciences and Health Care, MaRS
Panelists:
Mark Lundie, Director of R&D, Pfizer Canada
Michael May, CEO, The Centre for Commercialization of Regenerative Medicine (CCRM)
Niall Wallace, CEO, Infonaut Inc.
Aled Edwards, Director and CEO, Structural Genomics Consortium
MaRS – Building Canada’s next generation of global technology companies. marsdd.com
Related Videos
< back to list

















